Publications & Awards

PUBLISHED PAPERS

Di Lena M, Tolls V, Kelly KL, Nickel JC. (2017). Mirabegron as adjuvant treatment for patients with Interstitial Cystitis/Bladder Pain Syndrome. Can Urol Assoc J. [Epub ahead of print]
Doiron CR, Kogan B, Tolls V, Irvine-Bird K, Nickel JC. (2017). Childhood bladder and bowel dysfunction predicts IBS phenotype in adult IC/BPS patients. Can Urol Assoc J. 11(8):255-259.
Nickel JC, Tripp D, Beiko D, Tolls V, Herschorn S, Carr L, Kelly KL, Golda N. (2017). The Interstitial Cystitis/Bladder Pain Syndrome Clinical Picture (IC/BPS): A perspective from patients’ life experience. Urology Practice.
Lusty A, Kavaler E, Zakariasen K, Tolls V, Nickel JC. (2017). Treatment Effectiveness in Interstitial Cystitis / Bladder Pain Syndrome: Do Patients Perceptions Align with Efficacy Based Guidelines? J Urol. 197(4):e388 ,Supplement.
Doiron RC, Tolls V, Nickel JC. (2017). The Evolving Clinical Picture of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): a Look at 1310 Patients Over 16 Years. J Urol. 197(4S): e116, Supplement.
Doiron RC, Tolls V, Irvine-Bird K, Kelly KL, Nickel JC. (2016). Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy. J Urol. 196(4):1136-40
Cabrita MA, Vanzyl EJ, Hamill JD, Pan E, Marcellus KA, Tolls VJ, Alonzi RC, Pastic A, Rambo TM, Sayed H, McKay BC. (2016). A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing. PLoS One. 3;11(2):e0148529

Presentations

Heart rate variability response to vasopressor intervention in critically ill patients. AMIA 2018 Informatics Summit | 2018
Heart rate variability as a predictor for ICU illness severity and mortality | High Performance Computing Symposium (HPCS) | 2017

Awards/Fellowships/Grants

ACM SIGHPC/Intel Computational & Data Science Fellowship | 2016 & 2017

Queen's Graduate Studies | 2016 & 2017